MALAT1 and Sepsis: Recent investigations have revealed artesunate’s capacity to modulate various molecular pathways, including the MALAT1/PTBP1/IFIH1 axis in sepsis [16], long non-coding RNA RP-11 in hepatic epithelial-mesenchymal transition (EMT) [17], and the MALAT1/YAP signaling pathway in C918 cells [18].